Back to search

Article

An early Indian experience with benralizumab - A compendium on severe asthma cases: a case series

2023-09-27

Abstract excerpt

<h4>Background: </h4> Severe eosinophilic asthma (SEA), one of the phenotypes of asthma that is characterized by elevated blood eosinophil counts, is a common cause of uncontrolled asthma. Patients with SEA often experience severe persistent symptoms and have frequent exacerbations despite optimal inhaler therapy. They also have poor lung function and quality of life (QoL). Benralizumab (Fasenra), a monoclonal ant...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
89332ad9-d716-5970-b058-3f84f98c2d20
DOI
10.12688/f1000research.132704.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An early Indian experience with benralizumab - A compendium on severe asthma cases: a case seriesDOI 10.12688/f1000research.132704.1
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis.Semantic proximity
Benralizumab: The Immuno-Pharmacological State of the ArtSemantic proximity
Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotype.Semantic proximity
Treatment of Chronic Spontaneous Urticaria With Benralizumab: Report of Primary Endpoint Completer Analysis, Secondary and Exploratory EndpointsSemantic proximity
¿p#1 Multidomain Clinical and Biological Remission with Tezepelumab in Severe Asthma: A 12-Month Multicentre Real-World StudySemantic proximity
Reslizumab (Cinqair) for severe eosinophilic asthma.Semantic proximity
Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study.Semantic proximity
The effect of biologics on lung function improvements among severe eosinophilic asthma patients with partial reversibility or fixed obstructive defects: A retrospective analysisSemantic proximity
Monoclonal Antibodies in Idiopathic Chronic Eosinophilic Pneumonia: A Scoping ReviewSemantic proximity
Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) In Paediatric Severe Allergic Asthma – A Romanian PerspectiveSemantic proximity
Cross-sectional study to describe allergic rhinitis flare-ups and associated airways phenotype in house dust mite sensitization.Semantic proximity
Effectiveness of mepolizumab in a real-life cohort of patients with severe refractory eosinophilic asthma and multiple comorbiditiesSemantic proximity
Select a neighboring publication to make it the new centre.